A New Oral Option for Management of Endometriosis-Associated Pain

2020-10-06T02:16:59-05:00

FDA approval of gonadotropin-releasing hormone (GnRH) antagonist elagolix as an oral agent for management of moderate-to-severe pain associated with endometriosis provides an important treatment option for a condition that compromises quality of life for approximately 10% of women of reproductive age. Types of pain associated with endometriosis include painful periods, painful ovulation, pain during or [...]

A New Oral Option for Management of Endometriosis-Associated Pain2020-10-06T02:16:59-05:00

An Update on Women’s Unmet Medical Needs: National Women’s Health Week 2018

2020-10-13T15:17:34-05:00

A post in this blog during National Women's Health Week 2016 discussed six areas of significant unmet medical needs in women's health. This post for National Women's Health Week 2018 provides an update on the status of product development in addressing three of those areas of unmet need. Increased availability of noninvasive diagnostics for health conditions [...]

An Update on Women’s Unmet Medical Needs: National Women’s Health Week 20182020-10-13T15:17:34-05:00
Go to Top